These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9272138)

  • 1. Dose-intensive chemotherapy in extensive-stage small-cell lung cancer.
    Negoro S; Masuda N; Furuse K; Saijo N; Fukuoka M
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S70-3. PubMed ID: 9272138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group.
    Furuse K; Fukuoka M; Nishiwaki Y; Kurita Y; Watanabe K; Noda K; Ariyoshi Y; Tamura T; Saijo N
    J Clin Oncol; 1998 Jun; 16(6):2126-32. PubMed ID: 9626212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
    Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y; Ohe Y
    Eur J Cancer; 1994; 30A(2):188-94. PubMed ID: 7512356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.
    Fukuoka M; Masuda N; Negoro S; Matsui K; Yana T; Kudoh S; Kusunoki Y; Takada M; Kawahara M; Ogawara M; Kodama N; Kubota K; Furuse K
    Br J Cancer; 1997; 75(2):306-9. PubMed ID: 9010043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
    J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly dose-intensive chemotherapy in patients with small-cell lung cancer: a pilot study.
    Kudoh S; Fukuoka M; Negoro S; Tanaka H; Kusunoki Y; Matsui K; Masuda N; Takifugi N; Itoh K; Nishioka M
    Am J Clin Oncol; 1992 Feb; 15(1):29-34. PubMed ID: 1372463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly CODE chemotherapy with recombinant human granulocyte colony-stimulating factor for relapsed or refractory small cell lung cancer.
    Sato K; Tsuchiya S; Minato K; Sunaga N; Ishihara SI; Makimoto T; Naruse I; Hoshino H; Watanabe S; Saitoh R; Mori M
    Oncol Rep; 2000; 7(5):1135-9. PubMed ID: 10948352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dose intensity chemotherapy in lung cancer].
    Takada M; Fukuoka M; Negoro S; Masuda N; Kudo S
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2005-12. PubMed ID: 1699498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer.
    Woll PJ; Hodgetts J; Lomax L; Bildet F; Cour-Chabernaud V; Thatcher N
    J Clin Oncol; 1995 Mar; 13(3):652-9. PubMed ID: 7533825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.
    Pujol JL; Douillard JY; Rivière A; Quoix E; Lagrange JL; Berthaud P; Bardonnet-Comte M; Polin V; Gautier V; Milleron B; Chomy F; Chomy P; Spaeth D; Le Chevalier T
    J Clin Oncol; 1997 May; 15(5):2082-9. PubMed ID: 9164221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trial.
    Sandler A; Blanke C; Monaco F; Carey MA; Ansari R; Fisher B; Spiridonidis CH; Einhorn L; Nichols C
    Am J Clin Oncol; 1998 Jun; 21(3):294-7. PubMed ID: 9626802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group.
    Murray N; Livingston RB; Shepherd FA; James K; Zee B; Langleben A; Kraut M; Bearden J; Goodwin JW; Grafton C; Turrisi A; Walde D; Croft H; Osoba D; Ottaway J; Gandara D
    J Clin Oncol; 1999 Aug; 17(8):2300-8. PubMed ID: 10561291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer.
    Hastürk S; Kurt B; Kocabas A; Orüç O; Burgut R
    J Chemother; 1997 Feb; 9(1):66-71. PubMed ID: 9106021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer.
    Kubota K; Nishiwaki Y; Kakinuma R; Hojo F; Matsumoto T; Ohmatsu H; Sekine I; Yokozaki M; Goto K; Ebi N; Kodama T
    J Clin Oncol; 1997 Jan; 15(1):292-6. PubMed ID: 8996155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CODE chemotherapy with or without recombinant human granulocyte colony-stimulating factor in extensive-stage small cell lung cancer.
    Masuda N; Fukuoka M; Furuse K
    Oncology; 1992; 49 Suppl 1():19-24. PubMed ID: 1380148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy for small cell lung cancer].
    Fukuoka M; Takada M; Masuda N; Furuse K; Saijo N; Ikegami H; Nishiwaki Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():225-31. PubMed ID: 7516450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.
    Miles DW; Fogarty O; Ash CM; Rudd RM; Trask CW; Spiro SG; Gregory WM; Ledermann JA; Souhami RL; Harper PG
    J Clin Oncol; 1994 Jan; 12(1):77-82. PubMed ID: 7505809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer.
    Murray N; Shah A; Osoba D; Page R; Karsai H; Grafton C; Goddard K; Fairey R; Voss N
    J Clin Oncol; 1991 Sep; 9(9):1632-8. PubMed ID: 1651995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working Party.
    Thatcher N; Clark PI; Smith DB; Anderson H; Girling DJ; Machin D; Stephens RJ; Lallemand G; Jenkins B
    Clin Oncol (R Coll Radiol); 1995; 7(5):293-9. PubMed ID: 8580054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.